foscarnet
Selected indexed studies
- Foscarnet-Induced Penile Ulceration. (JAMA Dermatol, 2023) [PMID:37647057]
- Clinical pharmacology: foscarnet. (Am J Med, 1992) [PMID:1371039]
- Once-Daily Foscarnet Is Effective for Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation. (Transplant Cell Ther, 2023) [PMID:36878429]
_Worker-drafted node — pending editorial review._
Connections
foscarnet is a side effect of
Sources
- Foscarnet-Induced Penile Ulceration. (2023) pubmed
- Clinical pharmacology: foscarnet. (1992) pubmed
- Once-Daily Foscarnet Is Effective for Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation. (2023) pubmed
- Foscarnet-Associated Nephrogenic Diabetes Insipidus. (2022) pubmed
- Foscarnet. (1998) pubmed
- Foscarnet Versus Ganciclovir for Severe Congenital Cytomegalovirus Infection: Short- and Long-Term Follow-Up. (2025) pubmed
- Review of the toxicities of foscarnet. (1992) pubmed
- Foscarnet. (1985) pubmed
- Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections. (1994) pubmed
- Foscarnet in the management of cytomegalovirus infections in hematopoietic stem cell transplant patients. (2012) pubmed